Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia

被引:13
|
作者
De Nunzio, Cosimo [1 ]
Giglio, Simona [2 ]
Stoppacciaro, Antonella [2 ]
Gacci, Mauro [4 ]
Cirombella, Roberto [2 ]
Luciani, Emidio [2 ]
Tubaro, Andrea [1 ]
Vecchione, Andrea [2 ,3 ]
机构
[1] Sapienza Univ, Osped St Andrea, Dept Clin & Mol Med, Urol Units, Rome, Italy
[2] Sapienza Univ, Osped St Andrea, Dept Clin & Mol Med, Surg Pathol Units, Rome, Italy
[3] Ohio State Univ, CCC, Dept Canc Biol & Genet, Columbus, OH 43210 USA
[4] Careggi Hosp, Dept Urol, Florence, Italy
关键词
autophagy; BPH; LUTS; inflammation; prostate; METABOLIC SYNDROME; REGULATES INFLAMMATION; PATHOGENESIS; OBESITY;
D O I
10.18632/oncotarget.15144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Autophagy is a conserved evolutionary process that allows cells to maintain macromolecular synthesis and energy homeostasis during starvation and stressful conditions. We prospectively evaluated the relationship between autophagy and prostatic inflammation in a series of transurethral prostatic resection samples. Inflammatory infiltrates were defined according to the standardized classification of chronic prostatitis of the National Institute of Health. The inflammatory score (IS score) was calculated. High IS score was defined as >= 7. Each sample was stained for anti-LC3B and for anti-P62/SQSTM1 and scored. High p62 or LC3B percentage was defined as > 25%, whereas low was defined as < 25% of cells with dots. We analyzed 94 specimens. Overall, 18/94 (19%) showed no sign of prostatic inflammation, whereas 76/94 (81%) presented inflammatory infiltrates. Inflammation was mild in 61/76 (80%), moderate/severe in 15/76 (20%). Patients with high p62 percentage were 62/94 (66%) while 32 (34%) showed low p62 percentage. Patients with high LC3B percentage were 37/94 (39%) while 57(61%) showed low LC3B percentage. Overall 42/94 (44%) patients presented a high p62 percentage and concomitant a low LC3B percentage. IS score was significantly higher in patients with a with high p62 percentage (median IS 7 (6/8) vs 5 (3/7); p=0.04) and in patients with a low LC3B percentage (median IS 7 (6/8) vs 5 (3/7); p=0.004) when compared to patients with a low p62 percentage or a high LC3B percentage respectively. On multivariate analysis, p62 (OR: 10.1, 95% CI: 2.6-38.6; p=0,001) and LC3B expression (OR: 0.319; 95% CI: 0.112-0.907; p=0.032) were independent predictors of a high IS. Here we present the first evidence of autophagy deregulation in prostatic inflammation. These results raise many questions about the mechanisms mediating the autophagy dysfunction and the links to prostatic inflammation that need to be addressed.
引用
收藏
页码:50904 / 50910
页数:7
相关论文
共 50 条
  • [41] Lower urinary tract symptoms, benign prostatic hyperplasia, and sexual dysfunction
    Park J.K.
    Köhler T.S.
    McVary K.T.
    Current Bladder Dysfunction Reports, 2008, 3 (4) : 233 - 240
  • [42] National Trends in the Management of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
    Mahon, Joseph T.
    Welliver, Charles
    CURRENT UROLOGY REPORTS, 2020, 21 (12)
  • [43] The medical management of lower urinary tract symptoms and benign prostatic hyperplasia
    Holtgrewe, HL
    UROLOGIC CLINICS OF NORTH AMERICA, 1998, 25 (04) : 555 - +
  • [44] Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms
    Parsons, J. K.
    CURRENT OPINION IN UROLOGY, 2011, 21 (01) : 1 - 4
  • [45] Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms
    Parsons, J. Kellogg
    Kashefi, Carol
    EUROPEAN UROLOGY, 2008, 53 (06) : 1228 - 1235
  • [46] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: Research Priorities
    De Nunzio, Cosimo
    Ahyai, Sascha
    Autorino, Riccardo
    Bachmann, Alexander
    Bialek, Waldemar
    Briganti, Alberto
    Reich, Oliver
    Sosnowski, Roman
    Thiruchelvam, Nikesh
    Novara, Giacomo
    EUROPEAN UROLOGY, 2011, 60 (06) : 1205 - 1206
  • [47] Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Dedhia, Raj C.
    McVary, Kevin T.
    JOURNAL OF UROLOGY, 2008, 179 (06): : 2119 - 2125
  • [48] Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome
    Linda Vignozzi
    Mauro Gacci
    Mario Maggi
    Nature Reviews Urology, 2016, 13 : 108 - 119
  • [49] Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia
    van Venrooij, GEPM
    Eckhardt, MD
    Boon, TA
    UROLOGY, 2004, 63 (03) : 476 - 480
  • [50] EFFECT OF TYPE AND LOCATION OF PROSTATIC CALCULI ON LOWER URINARY TRACT SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA
    Kim, H. W.
    Kim, S. H.
    Lee, Y. S.
    Lee, J. Y.
    Kim, S. W.
    Lee, D. H.
    Cho, S. Y.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 236 - 236